Skip to main content
John Mullinax, MD, General Surgery, Tampa, FL

JohnMullinaxMD

General Surgery • Tampa, FL

Surgical Oncology (Other than Breast)

Associate Member, Surgical Oncology Sarcoma Department Immunology Program Surgical Director, Cell Therapy Program H. Lee Moffitt Cancer Center

Request Appointment

Overview of Dr. Mullinax

Dr. John Mullinax is a general surgeon in Tampa, FL and is affiliated with multiple hospitals in the area, including H. Lee Moffitt Cancer Center and Research Institute, James A. Haley Veterans' Hospital-Tampa, and Tampa General Hospital. He received his medical degree from University of South Florida Morsani College of Medicine and has been in practice 10 years. He is one of 92 doctors at H. Lee Moffitt Cancer Center and Research Institute and one of 39 doctors at James A. Haley Veterans' Hospital-Tampa who specialize in General Surgery. He has more than 60 publications and over 500 citings.

Education & Training

  • University of South Florida Morsani
    University of South Florida MorsaniFellowship, Complex General Surgical Oncology, 2014 - 2016
  • University of South Florida Morsani
    University of South Florida MorsaniResidency, Surgery, 2007 - 2014
  • National Cancer Institute
    National Cancer Institute2010 - 2012
  • University of South Florida College of Medicine
    University of South Florida College of MedicineClass of 2007

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2010 - 2026
  • American Board of Surgery Surgery
  • American Board of Surgery Complex General Surgical Oncology

Awards, Honors, & Recognition

  • Resident of the Year Department of Surgery, USF College of Medicine, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Tumor Inflammation and Myeloid Derived Suppressor Cells Reduce the Efficacy of CD19 CAR T Cell Therapy in Lymphoma
    John E Mullinax, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • The Lymphoma Tumor Microenvironment Influences Toxicity after CD19 CAR T Cell Therapy
    John E Mullinax, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Press Mentions

  • Researchers at Johns Hopkins All Children’s Seek to Adapt Adult Treatments to Fight Pediatric Cancers
    Researchers at Johns Hopkins All Children’s Seek to Adapt Adult Treatments to Fight Pediatric CancersSeptember 6th, 2019
  • Chemotherapy Approach Avoids Amputation in Sarcoma Patients
    Chemotherapy Approach Avoids Amputation in Sarcoma PatientsMarch 22nd, 2017
  • Three Nonprofit Organizations Step up to Fund Unique Pediatric Cancer Clinical Trial
    Three Nonprofit Organizations Step up to Fund Unique Pediatric Cancer Clinical TrialDecember 26th, 2023

Professional Memberships

External Links

Dr. John Mullinax, Dr. John Mullinax, MD, Dr. J Mullinax